Advertisement
Advertisement
AUTL
Autolus Therapeutics plc - ADR
1.32
USDSponsored
0.00
0.00%
Nov 10, 15:59 UTC -5
Closed
After-Market
1.32
0.00
-0.30%
Autolus Therapeutics plc - ADR (AUTL) Earnings
AUTL Earnings Reports
Positive Surprise Ratio
AUTL beat 15 of 31 last estimates.
48%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q3 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Autolus Therapeutics plc - ADR earnings per share and revenue
On Nov 10, 2026, AUTL reported earnings of -0.21 USD per share (EPS) for Q3 26, missing the estimate of -0.16 USD, resulting in a -27.20% surprise. Revenue reached 41.24 million, compared to an expected 40.33 million, with a 2.26% difference.
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Kura Oncology, Inc.
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.83
Actual
-$0.78
Surprise
+7.00%
Olema Pharmaceuticals, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.63
Actual
-$0.73
Surprise
-14.53%
Protalix BioTherapeutics, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.03
Actual
$0.05
Surprise
+265.02%
PepGen Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.27
Actual
-$0.28
Surprise
-1.19%
Humacyte, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.09
Actual
-$0.07
Surprise
+22.91%
Seer, Inc. Class A Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.25
Actual
-$0.25
Surprise
+1.96%
Scholar Rock Holding Corporation Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.86
Actual
-$0.81
Surprise
+6.18%
TELA Bio, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.16
Actual
-$0.13
Surprise
+20.54%
Atossa Therapeutics, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.90
Actual
-$0.56
Surprise
+38.31%
CalciMedica, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$1.30
Actual
-$0.72
Surprise
+44.64%
FAQ
What were Autolus Therapeutics plc - ADR's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Autolus Therapeutics plc - ADR reported EPS of -$0.21, missing estimates by -27.2%, and revenue of $41.24M, 2.26% above expectations.
How did the market react to Autolus Therapeutics plc - ADR's Q3 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Autolus Therapeutics plc - ADR expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Autolus Therapeutics plc - ADR's next earnings report?
Based on --
analysts, Autolus Therapeutics plc - ADR is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.